How to Become a Learner-Centered Teacher. In: Handbook of Clinical Teaching. Springer Nature; 2026:3-9.
Measuring the Impact: Magnetic Resonance Imaging Response of Sacroiliac Joints to Tumor Necrosis Factor Inhibitors in Youth With Axial Disease. Arthritis & Rheumatology. 2026; 78(7):1527-1534.
The Renal Activity Index for Lupus Identifies Active Renal Disease and Treatment Response in Adult Patients With Systemic Lupus Erythematosus and Lupus Nephritis. Arthritis Care and Research. 2026; 78(6):723-732.
Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients With Systemic Lupus Erythematosus: A Multicenter, Open-Label Trial. Arthritis Care and Research. 2026; 78(6):761-770.
Pharmacokinetics, effectiveness and safety of certolizumab pegol in children and adolescents with active juvenile idiopathic arthritis: 9+-year results from a multicenter, open-label study. Arthritis & Rheumatology. 2026.
Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial. Arthritis & Rheumatology. 2026; 78(3):752-762.
CAR T-cell therapy and indications for pediatric rheumatology: Structured overview of applications, risks, and considerations. Best Practice and Research: Clinical Rheumatology. 2026; 40(1):102143.
Measurement of haemolytic anaemia in a novel treatment response measure for SLE clinical trials. Lupus Science and Medicine. 2026; 13(1).
Dr. Eloseily et al reply. Journal of Rheumatology. 2026.
Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome. Journal of Rheumatology. 2026; 53(6):669-678.
What is the best way to plan a 12-month clinical drug trial in JIA associated uveitis? Expert Review of Clinical Immunology. 2026; 22(3):323-336.
Characterization of Pulmonary Dysfunction in Systemic Juvenile Idiopathic Arthritis Using Xenon and Proton MRI. Pediatric Pulmonology. 2026; 61(4):e71613.
Challenging traditional classifications: Gene penetrance in genetically transitional disease. Genes and Diseases. 2026; 102334.
Evaluation of steroids for acute COVID in the prevention of long COVID in children: An EHR and pediatric cohort study from the RECOVER Initiative. PLoS ONE. 2026; 21(6):e0350888.
Analysis of Neuron-derived Blood Exosomes in Anti-n-methyl-d-aspartate Receptor Encephalitis and Neuropsychiatric Lupus (P8-1.007) Neurology. 2026; 106(11_Supplement_1).
Cognitive Screening and Neuropsychological Evaluation in Children and Young Adults With Childhood-Onset Systemic Lupus Erythematosus: A Survey of Rheumatologists. ACR Open Rheumatology. 2026; 8(3):e90009.
399 Biopsychosocial Risk Influences on Development and Generation of Early-onset Pain: The BRIDGE Pain Study Protocol. Journal of Pain. 2026; 41:106046.
Pharmacokinetics and Safety of Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Results of the Real-World Ustekinumab Pediatric Opportunistic Pharmacokinetics Study (U-POPS). Rheumatology and Therapy. 2026; 13(1):265-278.
Speaking the same language: international cross-validation of emerging biomarkers for juvenile idiopathic arthritis and Still's Disease. Pediatric Rheumatology. 2026; 24(1).
Sex differences in clinical and imaging characteristics of axial juvenile spondyloarthritis. Rheumatology. 2026; 65(3).
Clinical characteristics and quality of life measures in children with glaucoma-suspect or glaucoma diagnoses in chronic, noninfectious uveitis. Journal of AAPOS. 2026; 30(2):104804.
Musculoskeletal and nail ultrasound findings in children with psoriasis: a case-control study. Pediatric Rheumatology. 2026; 24(1).
The Renal Activity Index for Lupus: Validation for Prediction of Kidney Inflammation in Adult Patients With Lupus Nephritis. Journal of Rheumatology. 2026; 53(3):283-291.
Physician-Scientist Pipeline for Pediatric Rheumatology: The Current Landscape and Future Perspectives. Arthritis Care and Research. 2026.
Reliability and Construct Validity of the Physician's Global Assessment of Lung Disease in Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease. ACR Open Rheumatology. 2026; 8(3):e90006.
Pathogenic and genetic landscape of Still's disease across ages, with new insights into age-related IL-18 patterns. Arthritis Research & Therapy. 2026; 28(1).
Distinct cytokine and chemokine alterations in bronchoalveolar fluid from patients with systemic juvenile idiopathic arthritis associated lung disease (SJIA-LD). Arthritis Research & Therapy. 2026.
2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus. Arthritis & Rheumatology. 2026; 78(7):1361-1386.
2025 American College of Rheumatology (ACR) Guideline for the Treatment of Systemic Lupus Erythematosus. Arthritis Care and Research. 2026; 78(7):815-839.
Characterization of TNF-Alpha Inhibitor Induced Paradoxical Psoriasiform Dermatitis at a Single Center via Retrospective Chart Review. Pediatric Dermatology. 2026; 43(1):84-87.
Soluble factors released from fibroblast-like synoviocytes of JIA patients with future extended course can condition persistent JIA synovial fibroblasts for increased IL-6 production. Arthritis Research & Therapy. 2026; 28(1).
Cumulative Social Disadvantage and Disease Activity in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry Study. Arthritis Care and Research. 2026.
Validation of the Pediatric Arthritis Ultrasound Scoring System for the Elbow, Wrist, and Finger Joints in Children With Juvenile Idiopathic Arthritis. Arthritis Care and Research. 2026; 78(7):905-913.
Potential role for immune cell signatures as predictors of acute and chronic pain in adolescents post major musculoskeletal surgery. Brain, Behavior, and Immunity. 2026; 131:106133.
Cyt-Geist: Current and Future Challenges in Cytometry: Reports of the CYTO 2025 Conference Workshops. Cytometry. Part A : the journal of the International Society for Analytical Cytology. 2026; 109(1):5-41.
From Adult to Adolescent: Alignment in Clinical Trials and Outcomes in Axial Spondyloarthritis. Arthritis Care and Research. 2026.
Facilitating Expedited Drug Approval-the Past, Present, and Future of Clinical Trials for Pediatric Rheumatic Disease. Arthritis Care and Research. 2026.
Juvenile Spondyloarthritis Disease Activity Index Validation in Enthesitis-Related Arthritis and Juvenile Psoriatic Arthritis in a Prospective Clinical Trial Setting. Journal of Rheumatology. 2026; 53(1):85-94.
Differences in time to drug initiation and inactive disease achievement by insurance type in patients with nonsystemic juvenile idiopathic arthritis. Drugs and Therapy Perspectives. 2026; 42(1):203-210.